LHX4
Basic information
Region (hg38): 1:180230264-180278984
Links
Phenotypes
GenCC
Source:
- short stature-pituitary and cerebellar defects-small sella turcica syndrome (Moderate), mode of inheritance: AD
- short stature-pituitary and cerebellar defects-small sella turcica syndrome (Strong), mode of inheritance: AD
- short stature-pituitary and cerebellar defects-small sella turcica syndrome (Definitive), mode of inheritance: AD
- short stature-pituitary and cerebellar defects-small sella turcica syndrome (Supportive), mode of inheritance: AD
- combined pituitary hormone deficiencies, genetic form (Supportive), mode of inheritance: AD
- pituitary stalk interruption syndrome (Supportive), mode of inheritance: AD
- hypothyroidism due to deficient transcription factors involved in pituitary development or function (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Pituitary hormone deficiency, combined, 4 | AD | Endocrine | Individuals can prevent neonatally with severe manifestations due to endocrine anomalies such as hypoglycemia; Respiratory distress has also been described at presentation; Other corrections of endocrine anomalies, such as growth hormone deficiency treatment, can be beneficial | Endocrine; Musculoskeletal; Neurologic; Pulmonary | 11567216; 17527005; 18073311; 19856252; 20534763; 22232309; 23029363; 23761422 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (77 variants)
- Short_stature-pituitary_and_cerebellar_defects-small_sella_turcica_syndrome (53 variants)
- Inborn_genetic_diseases (51 variants)
- not_specified (22 variants)
- LHX4-related_disorder (14 variants)
- Pituitary_hormone_deficiency,_combined,_1 (2 variants)
- Combined_Pituitary_Hormone_Deficiency,_Dominant (2 variants)
- Incidental_Discovery (1 variants)
- Combined_pituitary_hormone_deficiencies,_genetic_form (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LHX4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000033343.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 31 | 34 | ||||
missense | 93 | 10 | 109 | |||
nonsense | 2 | |||||
start loss | 1 | 1 | ||||
frameshift | 5 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
Total | 8 | 4 | 97 | 41 | 4 |
Highest pathogenic variant AF is 0.00000309768
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LHX4 | protein_coding | protein_coding | ENST00000263726 | 6 | 49960 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0175 | 0.978 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.670 | 205 | 234 | 0.877 | 0.0000143 | 2584 |
Missense in Polyphen | 76 | 88.8 | 0.85585 | 992 | ||
Synonymous | -0.479 | 100 | 94.1 | 1.06 | 0.00000610 | 749 |
Loss of Function | 2.51 | 6 | 17.3 | 0.348 | 8.53e-7 | 193 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000116 | 0.000116 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000264 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a critical role in the development of respiratory control mechanisms and in the normal growth and maturation of the lung. Binds preferentially to methylated DNA (PubMed:28473536). {ECO:0000250, ECO:0000269|PubMed:28473536}.;
- Disease
- DISEASE: Pituitary hormone deficiency, combined, 4 (CPHD4) [MIM:262700]: Combined pituitary hormone deficiency is defined as the impaired production of growth hormone and one or more of the other five anterior pituitary hormones. CPHD4 is characterized by complete or partial deficiencies of growth hormone, thyroid- stimulating hormone, luteinizing hormone, follicle stimulating hormone and adrenocorticotropic hormone. Clinical features include short stature, cerebellar defects, and small sella turcica. {ECO:0000269|PubMed:17527005, ECO:0000269|PubMed:18073311}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving LHX4 may be a cause of acute lymphoblastic leukemia. Translocation t(1;14)(q25;q32) with IGHG1. {ECO:0000269|PubMed:11567216}.;
- Pathway
- Developmental Biology;Regulation of expression of SLITs and ROBOs;Signaling by ROBO receptors;Axon guidance
(Consensus)
Recessive Scores
- pRec
- 0.204
Intolerance Scores
- loftool
- 0.155
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24.33
Haploinsufficiency Scores
- pHI
- 0.349
- hipred
- Y
- hipred_score
- 0.625
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.945
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lhx4
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- placenta development;motor neuron axon guidance;animal organ morphogenesis;medial motor column neuron differentiation;negative regulation of apoptotic process;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding;methyl-CpG binding;sequence-specific DNA binding;metal ion binding